Isobavachalcone sensitizes cells to E2‐induced paclitaxel resistance by down‐regulating CD44 expression in ER+ breast cancer cells

Oestrogen receptor (ER) is expressed in approximately 60%‐70% of human breast cancer. Clinical trials and retrospective analyses have shown that ER‐positive (ER+) tumours are more tolerant to chemotherapeutic drug resistance than ER‐negative (ER−) tumours. In addition, isobavachalcone (IBC) is known...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Shi, Junfeng, Chen, Yi, Chen, Wenxing, Tang, Cuiju, Zhang, Honghong, Chen, Yuetong, Yang, Xiuwei, Xu, Zhi, Wei, Jingsun, Chen, Jinfei
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201375/
https://ncbi.nlm.nih.gov/pubmed/30179299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13719
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars